Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) Net Income towards Common Stockholders (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with -$30.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Net Income towards Common Stockholders fell 1392.96% year-over-year to -$30.5 million, compared with a TTM value of -$35.4 million through Sep 2025, down 159.54%, and an annual FY2024 reading of $4.2 million, up 118.41% over the prior year.
  • Net Income towards Common Stockholders was -$30.5 million for Q2 2025 at SRx Health Solutions, down from -$964000.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $24.8 million in Q2 2021 and bottomed at -$30.5 million in Q2 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$5.2 million, with a median of -$3.7 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders soared 234.37% in 2021, then plummeted 1392.96% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$5.1 million in 2021, then tumbled by 379.28% to -$24.4 million in 2022, then skyrocketed by 39.66% to -$14.7 million in 2023, then soared by 72.91% to -$4.0 million in 2024, then plummeted by 665.13% to -$30.5 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for SRXH at -$30.5 million in Q2 2025, -$964000.0 in Q1 2025, and -$4.0 million in Q4 2024.